Company performance
Add to research
Current Price
as of Jun 13, 2025$112.50
P/E Ratio
N/A
Market Cap
$2.17B
Description
Add to research
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Metrics
Add to research
Overview
- HQJupiter, FL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerLGND
- Price$112.5-1.70%
Trading Information
- Market cap$2.17B
- Float97.42%
- Average Daily Volume (1m)113,774
- Average Daily Volume (3m)119,067
- EPS-$7.12
Company
- Revenue$181.49M
- Rev growth (1yr)46.34%
- Net income-$42.45M
- Gross margin71.09%
- EBITDA margin-60.26%
- EBITDA-$27.32M
- EV$1.81B
- EV/Revenue9.99
- P/EN/A
- P/S11.90
- P/B2.73
- Debt/Equity0.56
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia